NCT04895436 · Interventional trial
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
Overall registry status Recruiting
Phase 2
Conditions Chronic Lymphocytic Leukemia (CLL)
Delaware Valley sites
- Pennsylvania Oncology Hematolo /ID# 249637 · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory